<bill session="114" type="s" number="2543" updated="2017-06-02T23:37:22Z">
  <state datetime="2016-02-11">REFERRED</state>
  <status>
    <introduced datetime="2016-02-11"/>
  </status>
  <introduced datetime="2016-02-11"/>
  <titles>
    <title type="short" as="introduced">Changing the Culture of the FDA Act</title>
    <title type="official" as="introduced">A bill to direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.</title>
    <title type="display">Changing the Culture of the FDA Act</title>
  </titles>
  <sponsor id="412391"/>
  <cosponsors/>
  <actions>
    <action datetime="2016-02-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2016-02-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2016-02-11T05:00:00Z" status="Introduced in Senate">Changing the Culture of the FDA Act

This bill requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)</summary>
  <committee-reports/>
</bill>
